RLAY
Relay Therapeutics, Inc.
Stock
$18.96+0.47 (+2.54%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $10M | −28.6% |
| Operating income | −$310M | — |
| Net income | −$286M | — |
| EPS | −$1.57 | — |
| Free cash flow | −$262M | — |
Relay Therapeutics, Inc.
$18.96+0.47 (+2.54%)Close Oct 2, 2026
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $10M | −28.6% |
| Operating income | −$310M | — |
| Net income | −$286M | — |
| EPS | −$1.57 | — |
| Free cash flow | −$262M | — |